Time-dependent vascular effects of endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPARγ )

PPAR Research

Volumn , Issue , 2009, Pages

  O'Sullivan, Saoirse E ^a   Kendall, David A ^a   Randall, Michael D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 CHLORO 5 NITROBENZANILIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; N ARACHIDONOYL DOPAMINE; NITRIC OXIDE SYNTHASE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; COMPETITIVE INHIBITION; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM; MALE; NONHUMAN; PROTEIN SYNTHESIS; RAT; VASCULARIZATION; VASODILATATION;

EID: 65649119353     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2009/425289     Document Type: Article

References (43)

1. Janke J., Schupp M., Engeli S., Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor- activation Journal of Hypertension 2006 24 9 1809 1816 (Pubitemid 44253243)
2. Jasiska M., Owczarek J., Orszulak-Michalak D., Statins: a new insight into their mechanisms of action and consequent pleiotropic effects Pharmacological Reports 2007 59 5 483 499
3. Schupp M., Curtin J. C., Kim R. J., Billin A. N., Lazar M. A., A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor- activity Molecular Pharmacology 2007 71 5 1251 1257 (Pubitemid 46658678)
4. Salam N. K., Huang T. H.-W., Kota B. P., Kim M. S., Li Y., Hibbs D. E., Novel PPAR-gamma agonists identified from a natural product library: a virtual screening, induced-fit docking and biological assay study Chemical Biology Drug Design 2008 71 1 57 70
5. Kuroyanagi K., Kang M.-S., Goto T., Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes Biochemical and Biophysical Research Communications 2008 366 1 219 225 (Pubitemid 50007730)
6. OSullivan S. E., Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors British Journal of Pharmacology 2007 152 5 576 582 (Pubitemid 350034977)
7. Kozak K. R., Gupta R. A., Moody J. S., 15-lipoxygenase metabolism of 2-arachidonylglycerol: generation of a peroxisome proliferator-activated receptor agonist The Journal of Biological Chemistry 2002 277 26 23278 23286
8. Fu J., Gaetani S., Oveisi F., Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR- Nature 2003 425 6953 90 93 (Pubitemid 37101723)
9. Guzmn M., Lo Verme J., Fu J., Oveisi F., Blzquez C., Piomelli D., Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor (PPAR- ) The Journal of Biological Chemistry 2004 279 27 27849 27854 (Pubitemid 38900052)
10. Lo Verme J., Fu J., Astarita G., The nuclear receptor peroxisome proliferator-activated receptor- mediates the anti-inflammatory actions of palmitoylethanolamide Molecular Pharmacology 2005 67 1 15 19 (Pubitemid 40069962)
11. Sun Y., Alexander S. P. H., Kendall D. A., Bennett A. J., Cannabinoids and PPAR signalling Biochemical Society Transactions 2006 34 6 1095 1097 (Pubitemid 46768996)
12. Liu J., Li H., Burstein S. H., Zurier R. B., Chen J. D., Activation and binding of peroxisome proliferator-activated receptor by synthetic cannabinoid ajulemic acid Molecular Pharmacology 2003 63 5 983 992 (Pubitemid 36529916)
13. OSullivan S. E., Tarling E. J., Bennett A. J., Kendall D. A., Randall M. D., Novel time-dependent vascular actions of 9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma Biochemical and Biophysical Research Communications 2005 337 3 824 831 (Pubitemid 41446988)
14. Rockwell C. E., Kaminski N. E., A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes Journal of Pharmacology and Experimental Therapeutics 2004 311 2 683 690 (Pubitemid 39391556)
15. Rockwell C. E., Snider N. T., Thompson J. T., Vanden Heuvel J. P., Kaminski N. E., Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor independently of cannabinoid receptors 1 and 2 Molecular Pharmacology 2006 70 1 101 111 (Pubitemid 43920800)
16. Bouaboula M., Hilairet S., Marchand J., Fajas L., Le Fur G., Casellas P., Anandamide induced PPAR transcriptional activation and 3T3-L1 preadipocyte differentiation European Journal of Pharmacology 2005 517 3 174 181 (Pubitemid 40977892)
17. Gasperi V., Fezza F., Pasquariello N., Endocannabinoids in adipocytes during differentiation and their role in glucose uptake Cellular and Molecular Life Sciences 2007 64 2 219 229 (Pubitemid 46155701)
18. OSullivan S. E., Bennett A. J., Kendall D. A., Randall M. D., Cannabinoids and peroxisome proliferator-activated receptor gamma (PPAR ) Proceedings of the International Cannabinoid Research Society (ICRS 06) June 2006 Tihany, Hungary 59
19. OSullivan S. E., Kendall D. A., Randall M. D., Further characterization of the time-dependent vascular effects of 9 -tetrahydrocannabinol Journal of Pharmacology and Experimental Therapeutics 2006 317 1 428 438
20. Hwang J., Kleinhenz D. J., Lassgue B., Griendling K. K., Dikalov S., Hart C. M., Peroxisome proliferator-activated receptor- ligands regulate endothelial membrane superoxide production American Journal of Physiology 2005 288 4 C899 C905 (Pubitemid 40395068)
21. Zygmunt P. M., Petersson J., Andersson D. A., Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 1999 400 6743 452 457 (Pubitemid 29361798)
22. Harris D., McCulloch A. I., Kendall D. A., Randall M. D., Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed Journal of Physiology 2002 539 3 893 902 (Pubitemid 35175438)
23. OSullivan S. E., Kendall D. A., Randall M. D., Vascular effects of 9 -tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta European Journal of Pharmacology 2005 507 13 211 221 (Pubitemid 40126857)
24. Offertler L., Mo F.-M., Btkai S., Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor Molecular Pharmacology 2003 63 3 699 705 (Pubitemid 36297343)
25. Hoi P. M., Hiley C. R., Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor British Journal of Pharmacology 2006 147 5 560 568 (Pubitemid 43355054)
26. Cunnane S. E., Chan Y. Y., Randall M. D., Rosiglitazone-induced vasorelaxation in the rat aorta Proceedings of the British Pharmacological Society 2004 2 2, abstract 096P
27. Randall M. D., Kendall D. A., OSullivan S. E., The complexities of the cardiovascular actions of cannabinoids British Journal of Pharmacology 2004 142 1 20 26 (Pubitemid 38698188)
28. Yano M., Matsumura T., Senokuchi T., Statins activate peroxisome proliferator-activated receptor through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages Circulation Research 2007 100 10 1442 1451 (Pubitemid 46834756)
29. Upham B. L., Rummel A. M., Carbone J. M., Cannabinoids inhibit gap junctional intercellular communication and activate ERK in a rat liver epithelial cell line International Journal of Cancer 2003 104 1 12 18 (Pubitemid 36184142)
30. Demuth D. G., Molleman A., Cannabinoid signalling Life Sciences 2006 78 6 549 563 (Pubitemid 41785760)
31. Bagi Z., Koller A., Kaley G., PPAR activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes American Journal of Physiology 2004 286 2 H742 H748 (Pubitemid 38140357)
32. Cho D.-H., Choi Y. J., Jo S. A., Jo I., Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) -dependent and PPAR -independent signaling pathways The Journal of Biological Chemistry 2004 279 4 2499 2506 (Pubitemid 38114233)
33. Ling H. Y., Feng S. D., Zhou S. H., Wang B. X., Liu X. Q., Hu B., Effects of rosiglitazone on aortic function in rats with insulin resistant-hypertension Sheng Li Xue Bao 2005 57 2 125 131
34. Majithiya J. B., Paramar A. N., Balaraman R., Pioglitazone, a PPAR agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats Cardiovascular Research 2005 66 1 150 161 (Pubitemid 40357878)
35. Bishop-Bailey D., Peroxisome proliferator-activated receptors in the cardiovascular system British Journal of Pharmacology 2000 129 5 823 834 (Pubitemid 30142890)
36. Hsueh W. A., Bruemmer D., Peroxisome proliferator-activated receptor : implications for cardiovascular disease Hypertension 2004 43 2 297 305 (Pubitemid 38174129)
37. Duan S. Z., Usher M. G., Mortensen R. M., Peroxisome proliferator- activated receptor- -mediated effects in the vasculature Circulation Research 2008 102 3 283 294
38. Underdown N. J., Hiley C. R., Ford W. R., Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism British Journal of Pharmacology 2005 146 6 809 816 (Pubitemid 41622247)
39. Lamontagne D., Lpicier P., Lagneux C., Bouchard J. F., The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia Archives des Maladies du Coeur et des Vaisseaux 2006 99 3 242 246 (Pubitemid 46211438)
40. Pacher P., Hask G., Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning British Journal of Pharmacology 2008 153 2 252 262
41. Btkai S., Pacher P., Osei-Hyiaman D., Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension Circulation 2004 110 14 1996 2002 (Pubitemid 39331913)
42. Sarzani R., Endocannabinoids, blood pressure and the human heart Journal of Neuroendocrinology 2008 20 supplement 1 58 62
43. Mach F., Steffens S., The role of the endocannabinoid system in atherosclerosis Journal of Neuroendocrinology 2008 20 supplement 1 53 57